Beloteca, Inc. develops and obtains regulatory approval of sterile pharmaceutical products. Our focus is on generic and 505(b)(2) reformulations. We target niche or difficult to manufacture products. Our model is to out-license these products to marketing partners.
Looking for a particular Beloteca, Inc. employee's phone or email?
The Beloteca, Inc. annual revenue was $3 million in 2026.
Fred Defesche is the CEO of Beloteca, Inc..
7 people are employed at Beloteca, Inc..
Beloteca, Inc. is based in San Diego, California.
The NAICS codes for Beloteca, Inc. are [325, 32, 3254, 32541].
The SIC codes for Beloteca, Inc. are [28, 283].